Date

Monday, 02 December 2019

Location

European Medicines Agency, Amsterdam, the Netherlands

This awareness session is organised for medicine regulators in the European medicines regulatory network, with places available for non-EU regulators as well.

It will provide an update on the progress of EMA's implementation activities for Regulation (EU) 2017/745 on Medical Devices (MDR) and Regulation (EU) 2017/746 on In-Vitro Diagnostic Devices.

A guest speaker from the United States Food and Drug Administartion (FDA) will attend to provide a global perspective on current activities in this area.

The session will focus on:

  • state of play of implementation of Medical Devices Regulation;
  • drug-device combinations – the forthcoming quality guidance;
  • a short journey into the emerging world of digital medicines;
  • combination products – a view from the FDA.

How useful do you find this page?